Clinical Trial Update: Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study [Phase 1]

View source ↗

Summary

Phase 1 safety and performance results for the Attune Tubing device by Cavu Medical, Inc. in obesity are reported; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Attune Tubing

Snippet

Sponsor: Cavu Medical, Inc. | Conditions: Obesity | Phase 1 | Status: COMPLETED